Idalia Dawidowska

Idalia Dawidowska is a highly qualified CEO, Executive, and Business Consultant with a strong background in managing teams and projects involving new technologies in the MedTech and Pharma industries.

She is passionate about addressing healthcare challenges and collaborating with diverse teams to create innovative solutions that meet global clinical, commercial, and social needs.

Idalia is known for her creativity, solution-oriented approach, and ability to inspire others, guiding them from problem-solving to vision, strategy, and implementation.

Her expertise includes entrepreneurship, management, capital raising, grant funding, pharma, medtech, commercialization strategy planning and execution, business models design, IP evaluation, new product development, regulatory affairs, market access, clinical development, sales & marketing, deals negotiation, and project management.

She holds a Strategyzer Masterclass in Business/Commerce from Strategyzer Academy, an MBA with Merit from Alliance Manchester Business School, and an MD in Medicine from Pomeranian Medical University.

Idalia has worked in various organizations, including The University of Sydney Business School as a Business Development Manager for Medicine and Health, Panthera Biopartners Ltd. as a Business Development Consultant, FUSE MedTech as a Co-Founder & Commercialisation Consultant, Renephra Ltd. as a CEO and Business Development Director, BioCity as Venture Development Manager - Alderley Park Accelerator, and held roles at Health 2.0, IF Sensing Ltd., ID Ventures Ltd., University of Manchester Intellectual Property (UMIP), and AstraZeneca in Central and Eastern Europe as a Regional Marketing Manager, Product Manager, and Medical Sales Representative.